FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3163162502> ?p ?o ?g. }

• W3163162502 endingPage "119608" @default.
• W3163162502 startingPage "119608" @default.
• W3163162502 abstract "The first-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), gefitinib, continues to be a primary treatment option for lung cancer patients. However, acquisition of resistance to gefitinib is a major obstacle in lung cancer treatment and its cause is poorly understood. The present study aimed to implicate the role of SOX9-β-catenin in developed resistance to gefitinib through epithelial to mesenchymal transition (EMT) in lung cancer in vitro and ex vivo. Expression effect of SOX9 on survivability of lung cancer patients was demonstrated through online available Kaplan-Meier Plotter data base. Then, cell viability assay, colony forming assay, cell migration and invasion assays, flow cytometry, drug efflux assay, qRT-PCR, and western blotting were conducted to confirmed the role of SOX9 in gefitinib resistance in lung cancer cells. Dual-luciferase assay established the regulatory relation between SOX9 and β-catenin. Multicellular spheroid assay further explored that down regulation of SOX9 could reverse gefitinib resistance ex vivo. Kaplan-Meier method correlated the higher expression of SOX9 and β-catenin with poor overall survival of lung cancer patients. Upregulation of SOX9 was associated gefitinib resistance with increased cell proliferation, migration and invasion, single-cell colony-forming ability, reduced apoptosis, and gefitinib intake in lung cancer cells. Moreover, upregulated SOX9 promoted EMT via targeting β-catenin and knockdown of SOX9 reversed the resistance and EMT phenotype. Similarly, we found that multicellular spheroid of gefitinib resistant cells showed larger surface area with more dispersion and viability of cells, while SOX9 knockdown abolished these induced properties ex vivo. SOX9 expression could provide an innovative perspective as biomarker to understand the EGFR-TKIs resistance in lung cancer." @default.
• W3163162502 created "2021-05-24" @default.
• W3163162502 creator A5010826437 @default.
• W3163162502 creator A5052314508 @default.
• W3163162502 date "2021-07-01" @default.
• W3163162502 modified "2023-09-25" @default.
• W3163162502 title "SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer" @default.
• W3163162502 cites W1482498723 @default.
• W3163162502 cites W1556792164 @default.
• W3163162502 cites W1856175162 @default.
• W3163162502 cites W1976215621 @default.
• W3163162502 cites W1990802782 @default.
• W3163162502 cites W1995337892 @default.
• W3163162502 cites W2055757796 @default.
• W3163162502 cites W2056840798 @default.
• W3163162502 cites W2078134150 @default.
• W3163162502 cites W2081801534 @default.
• W3163162502 cites W2088883749 @default.
• W3163162502 cites W2096262427 @default.
• W3163162502 cites W2097761831 @default.
• W3163162502 cites W2100751052 @default.
• W3163162502 cites W2126496132 @default.
• W3163162502 cites W2139419405 @default.
• W3163162502 cites W2144499341 @default.
• W3163162502 cites W2150322923 @default.
• W3163162502 cites W2156172510 @default.
• W3163162502 cites W2157923000 @default.
• W3163162502 cites W2264528830 @default.
• W3163162502 cites W2275816640 @default.
• W3163162502 cites W2302518824 @default.
• W3163162502 cites W2331628193 @default.
• W3163162502 cites W2401948163 @default.
• W3163162502 cites W2472306545 @default.
• W3163162502 cites W2500192509 @default.
• W3163162502 cites W2521161105 @default.
• W3163162502 cites W2593316971 @default.
• W3163162502 cites W2594353060 @default.
• W3163162502 cites W2757796401 @default.
• W3163162502 cites W2763998105 @default.
• W3163162502 cites W2777540525 @default.
• W3163162502 cites W2792821195 @default.
• W3163162502 cites W2806252578 @default.
• W3163162502 cites W2887314183 @default.
• W3163162502 cites W2942007182 @default.
• W3163162502 cites W2943005115 @default.
• W3163162502 cites W2979407281 @default.
• W3163162502 cites W2999417355 @default.
• W3163162502 cites W3037346151 @default.
• W3163162502 cites W3042312786 @default.
• W3163162502 cites W3126547044 @default.
• W3163162502 cites W4211233744 @default.
• W3163162502 cites W4294112996 @default.
• W3163162502 doi "https://doi.org/10.1016/j.lfs.2021.119608" @default.
• W3163162502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33989664" @default.
• W3163162502 hasPublicationYear "2021" @default.
• W3163162502 type Work @default.
• W3163162502 sameAs 3163162502 @default.
• W3163162502 citedByCount "7" @default.
• W3163162502 countsByYear W31631625022021 @default.
• W3163162502 countsByYear W31631625022022 @default.
• W3163162502 countsByYear W31631625022023 @default.
• W3163162502 crossrefType "journal-article" @default.
• W3163162502 hasAuthorship W3163162502A5010826437 @default.
• W3163162502 hasAuthorship W3163162502A5052314508 @default.
• W3163162502 hasConcept C121608353 @default.
• W3163162502 hasConcept C126322002 @default.
• W3163162502 hasConcept C142724271 @default.
• W3163162502 hasConcept C1491633281 @default.
• W3163162502 hasConcept C2776256026 @default.
• W3163162502 hasConcept C2779013556 @default.
• W3163162502 hasConcept C2779438470 @default.
• W3163162502 hasConcept C2780580887 @default.
• W3163162502 hasConcept C502942594 @default.
• W3163162502 hasConcept C53227056 @default.
• W3163162502 hasConcept C54355233 @default.
• W3163162502 hasConcept C71924100 @default.
• W3163162502 hasConcept C76419328 @default.
• W3163162502 hasConcept C86803240 @default.
• W3163162502 hasConceptScore W3163162502C121608353 @default.
• W3163162502 hasConceptScore W3163162502C126322002 @default.
• W3163162502 hasConceptScore W3163162502C142724271 @default.
• W3163162502 hasConceptScore W3163162502C1491633281 @default.
• W3163162502 hasConceptScore W3163162502C2776256026 @default.
• W3163162502 hasConceptScore W3163162502C2779013556 @default.
• W3163162502 hasConceptScore W3163162502C2779438470 @default.
• W3163162502 hasConceptScore W3163162502C2780580887 @default.
• W3163162502 hasConceptScore W3163162502C502942594 @default.
• W3163162502 hasConceptScore W3163162502C53227056 @default.
• W3163162502 hasConceptScore W3163162502C54355233 @default.
• W3163162502 hasConceptScore W3163162502C71924100 @default.
• W3163162502 hasConceptScore W3163162502C76419328 @default.
• W3163162502 hasConceptScore W3163162502C86803240 @default.
• W3163162502 hasFunder F4320334771 @default.
• W3163162502 hasLocation W31631625021 @default.
• W3163162502 hasOpenAccess W3163162502 @default.
• W3163162502 hasPrimaryLocation W31631625021 @default.
• W3163162502 hasRelatedWork W1976268611 @default.
• W3163162502 hasRelatedWork W1993958258 @default.

• next